|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalent | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Overnight deposits | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Investment securities available-for-sale, at fair value | ||||||||||||||||||||
| Investment securities held-to-maturity (estimated fair value of $369.5 million and $313.1 million at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Equity investment securities, at fair value | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Loans, net of deferred fees and costs | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Receivable from global payments business, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing demand deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| Federal Home Loan Bank of New York advances | ||||||||||||||||||||
| Trust preferred securities | ||||||||||||||||||||
| Secured and other borrowings | ||||||||||||||||||||
| Prepaid third-party debit cardholder balances | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock, $0.01 par value, 25,000,000 shares authorized, 13,614,067 and 11,300,191 shares issued; and 12,395,278 and 10,088,617 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | ||||||||||||||||||||
| Treasury stock, at cost, 1,218,789 and 1,211,574 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...